Non-canonical functions of a mutant TSC2 protein in mitotic division.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
02
2023
accepted:
12
09
2023
medline:
6
10
2023
pubmed:
4
10
2023
entrez:
4
10
2023
Statut:
epublish
Résumé
Tuberous Sclerosis Complex (TSC) is a debilitating developmental disorder characterized by a variety of clinical manifestations. TSC is caused by mutations in the TSC1 or TSC2 genes, which encode the hamartin/tuberin proteins respectively. These proteins function as a heterodimer that negatively regulates the mechanistic Target of Rapamycin Complex 1 (mTORC1). TSC research has focused on the effects of mTORC1, a critical signaling hub, on regulation of diverse cell processes including metabolism, cell growth, translation, and neurogenesis. However, non-canonical functions of TSC2 are not well studied, and the potential disease-relevant biological mechanisms of mutations affecting these functions are not well understood. We observed aberrant multipolar mitotic division, a novel phenotype, in TSC2 mutant iPSCs. The multipolar phenotype is not meaningfully affected by treatment with the inhibitor rapamycin. We further observed dominant negative activity of the mutant form of TSC2 in producing the multipolar division phenotype. These data expand the knowledge of TSC2 function and pathophysiology which will be highly relevant to future treatments for patients with TSC.
Identifiants
pubmed: 37792789
doi: 10.1371/journal.pone.0292086
pii: PONE-D-23-03345
pmc: PMC10550124
doi:
Substances chimiques
Mechanistic Target of Rapamycin Complex 1
EC 2.7.11.1
Mutant Proteins
0
Tuberous Sclerosis Complex 2 Protein
0
Tumor Suppressor Proteins
0
TSC2 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0292086Subventions
Organisme : NINDS NIH HHS
ID : R01 NS118580
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD007502
Pays : United States
Informations de copyright
Copyright: © 2023 Chalkley et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
MS reports grant support from Novartis, Biogen, Astellas, Aeovian, Bridgebio, and Aucta. He has served on Scientific Advisory Boards for Novartis, Roche, Regenxbio, SpringWorks Therapeutics, Jaguar Therapeutics and Alkermes. The other authors have no competing interests to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
N Engl J Med. 2011 Apr 28;364(17):1595-606
pubmed: 21410393
Lancet Oncol. 2008 Jan;9(1):73-9
pubmed: 18177819
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14352-7
pubmed: 11121038
Nat Rev Mol Cell Biol. 2020 Apr;21(4):183-203
pubmed: 31937935
Am J Hum Genet. 1996 Aug;59(2):400-6
pubmed: 8755927
Sci Rep. 2019 Feb 28;9(1):3015
pubmed: 30816188
Hum Mol Genet. 2006 Jan 15;15(2):287-97
pubmed: 16339216
J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):436-8
pubmed: 12235314
J Child Neurol. 2004 Sep;19(9):680-6
pubmed: 15563014
Genes Dev. 2003 Aug 1;17(15):1829-34
pubmed: 12869586
Neurology. 2013 Feb 5;80(6):574-80
pubmed: 23325902
Nat Neurosci. 2013 Nov;16(11):1537-43
pubmed: 24165680
Br J Cancer. 2001 Oct 19;85(8):1226-30
pubmed: 11710839
EMBO Mol Med. 2011 Apr;3(4):189-200
pubmed: 21412983
Hum Mol Genet. 2017 Dec 1;26(23):4629-4641
pubmed: 28973543
Lancet. 2016 Oct 29;388(10056):2153-2163
pubmed: 27613521
Curr Opin Neurol. 2010 Apr;23(2):189-93
pubmed: 20087180
Acta Neuropathol. 2013 Mar;125(3):317-32
pubmed: 23386324
Nat Commun. 2015 Aug 21;6:8077
pubmed: 26293378
Congenit Anom (Kyoto). 2007 Mar;47(1):2-8
pubmed: 17300684
Trends Cell Biol. 2008 Aug;18(8):379-88
pubmed: 18656360
Sci Rep. 2020 Jun 18;10(1):9909
pubmed: 32555378
Curr Biol. 2003 Aug 5;13(15):1259-68
pubmed: 12906785
Cell Cycle. 2010 Mar 15;9(6):1143-55
pubmed: 20237422
Mol Cell. 2012 Aug 24;47(4):535-46
pubmed: 22795129
Front Neuroanat. 2020 Jul 14;14:39
pubmed: 32765227
Am J Hum Genet. 2001 Jan;68(1):64-80
pubmed: 11112665
Eur J Hum Genet. 2005 Jun;13(6):731-41
pubmed: 15798777
Genes Dev. 2005 Sep 15;19(18):2199-211
pubmed: 16166381
Mol Psychiatry. 2018 Nov;23(11):2167-2183
pubmed: 29449635
Cell. 1993 Dec 31;75(7):1305-15
pubmed: 8269512
N Engl J Med. 2006 Sep 28;355(13):1345-56
pubmed: 17005952
Sci Rep. 2020 Apr 20;10(1):6589
pubmed: 32313033
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1432-7
pubmed: 9465032
Am J Hum Genet. 1999 May;64(5):1305-15
pubmed: 10205261
Science. 1997 Jul 4;277(5322):99-101
pubmed: 9204908
Science. 1997 Aug 8;277(5327):805-8
pubmed: 9242607
Genet Mol Res. 2013 Apr 12;12(2):1168-75
pubmed: 23661441
N Engl J Med. 2008 Jan 10;358(2):140-51
pubmed: 18184959
J Biol Chem. 1997 Oct 17;272(42):26457-63
pubmed: 9334222
Genes Dev. 1999 Jun 1;13(11):1422-37
pubmed: 10364159